These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21491633)

  • 1. Neuropsychological predictors of transition from healthy cognitive aging to mild cognitive impairment: The PATH through life study.
    Cherbuin N; Sachdev P; Anstey KJ
    Am J Geriatr Psychiatry; 2010 Aug; 18(8):723-33. PubMed ID: 21491633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
    Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
    Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH Through Life study.
    Cherbuin N; Anstey KJ
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):635-9. PubMed ID: 21937919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates.
    Schinka JA; Loewenstein DA; Raj A; Schoenberg MR; Banko JL; Potter H; Duara R
    Am J Geriatr Psychiatry; 2010 Aug; 18(8):684-91. PubMed ID: 21399729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study.
    Cherbuin N; Reglade-Meslin C; Kumar R; Jacomb P; Easteal S; Christensen H; Sachdev P; Anstey KJ
    Dement Geriatr Cogn Disord; 2009; 28(1):47-55. PubMed ID: 19628940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project.
    Ganguli M; Chang CC; Snitz BE; Saxton JA; Vanderbilt J; Lee CW
    Am J Geriatr Psychiatry; 2010 Aug; 18(8):674-83. PubMed ID: 20220597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study.
    Li L; Wang Y; Yan J; Chen Y; Zhou R; Yi X; Shi Q; Zhou H;
    J Neurol; 2012 Jul; 259(7):1303-11. PubMed ID: 22186849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective health and memory predictors of mild cognitive disorders and cognitive decline in ageing: the Personality and Total Health (PATH) through Life Study.
    Sargent-Cox K; Cherbuin N; Sachdev P; Anstey KJ
    Dement Geriatr Cogn Disord; 2011; 31(1):45-52. PubMed ID: 21150203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Cognitive and Functional Decline Using the Telephone-Administered Minnesota Cognitive Acuity Screen.
    Tremont G; Papandonatos GD; Kelley P; Bryant K; Galioto R; Ott BR
    J Am Geriatr Soc; 2016 Mar; 64(3):608-13. PubMed ID: 27000332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.
    Bartrés-Faz D; Junqué C; López-Alomar A; Valveny N; Moral P; Casamayor R; Salido A; Bel C; Clemente IC
    J Am Geriatr Soc; 2001 Jul; 49(7):985-90. PubMed ID: 11527492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of changes in cognitive functioning in the elderly: age- and education-specific reliable change indices for the SIDAM.
    Stein J; Luppa M; Maier W; Tebarth F; Heser K; Scherer M; Zimmermann T; Eisele M; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Wiese B; Prokein J; König HH; Leicht H; Riedel-Heller SG;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):73-83. PubMed ID: 22414525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing mild cognitive disorders in the young-old over 8 years: prevalence, estimated incidence, stability of diagnosis, and impact on IADLs.
    Anstey KJ; Cherbuin N; Eramudugolla R; Sargent-Cox K; Easteal S; Kumar R; Sachdev P
    Alzheimers Dement; 2013 Nov; 9(6):640-8. PubMed ID: 23474041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study.
    Zanetti M; Ballabio C; Abbate C; Cutaia C; Vergani C; Bergamaschini L
    J Am Geriatr Soc; 2006 Apr; 54(4):580-6. PubMed ID: 16686866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of five neuropsychological approaches to defining mild cognitive impairment.
    Jak AJ; Bondi MW; Delano-Wood L; Wierenga C; Corey-Bloom J; Salmon DP; Delis DC
    Am J Geriatr Psychiatry; 2009 May; 17(5):368-75. PubMed ID: 19390294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.
    Manly JJ; Bell-McGinty S; Tang MX; Schupf N; Stern Y; Mayeux R
    Arch Neurol; 2005 Nov; 62(11):1739-46. PubMed ID: 16286549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
    Chételat G; Eustache F; Viader F; De La Sayette V; Pélerin A; Mézenge F; Hannequin D; Dupuy B; Baron JC; Desgranges B
    Neurocase; 2005 Feb; 11(1):14-25. PubMed ID: 15804920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.